4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000055
EVP, Chief Business Officer sold 4,430 shares at $32.70 ($144,861)
- EVP, Chief Business Officer acquired 11,247 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Exercise or conversion : show line 1 in the form | +8,787 | 28,418 | D | ||
| 2025-01-16 | Sale : show line 2 in the form | −3,401 | $32.70 | $111,213 | 25,017 | D |
| 2025-01-15 | Exercise or conversion : show line 3 in the form | +2,460 | 4,100 | I | ||
| 2025-01-16 | Sale : show line 4 in the form | −1,029 | $32.70 | $33,648 | 3,071 | I |
| Open-market sales · 4,430 sh · avg $32.70 · $144,861 | ||||||
Table II: Derivative
5 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Grant or award : show line 5 in the form Performance Restricted Stock Units | +22,000 | $0.00 | 22,000 | 51,290 | D |
| 2025-01-15 | Grant or award : show line 6 in the form Restricted Stock Unit | +33,000 | $0.00 | 33,000 | 86,135 | D |
| 2025-01-15 | Exercise or conversion : show line 7 in the form Restricted Stock Unit | −8,787 | $0.00 | 8,787 | 77,348 | D |
| 2025-01-15 | Grant or award : show line 8 in the form Restricted Stock Unit | +3,750 | $0.00 | 3,750 | 10,784 | I |
| 2025-01-15 | Exercise or conversion : show line 9 in the form Restricted Stock Unit | −2,460 | $0.00 | 2,460 | 8,324 | I |
Loading xslF345X05/edgardoc.xml…